Increased Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs
Authors:
- Chia-Hsuin ChangCCChia-Hsuin Chang
- Wen-Yi ShauWSWen-Yi Shau
- Chuei-Wen KuoCKChuei-Wen Kuo
- Shu-Ting ChenSCShu-Ting Chen
- Mei-Shu LaiMLMei-Shu Lai
- 1 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (9) , 1884-1890
Abstract
Background and Purpose—Limited studies assessed cerebrovascular safety of individual nonsteroidal anti-inflammatory drugs (NSAIDs). We evaluated the risk of ischemic and hemorrhagic stroke associated with short-term use of selective and nonselective NSAIDs in a Chinese population with a high incidence of stroke.Methods—A retrospective case–crossover study was conducted by analyzing the Taiwan National Health Insurance Database. We identified all ischemic and hemorrhagic stroke patients in 2006, aged ≥20 years, based on International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes from inpatient claims and defined the index date as the date of hospitalization. For each patient, we defined case period as 1 to 30 days before the index date and control period as 91 to 120 days before the index date. A pharmacy prescription database was searched for NSAID use during the case and control periods. We calculated adjusted ORs and their 95% CIs with a conditional logistic regression model.Results—A total of 28 424 patients with ischemic stroke and 9456 patients with hemorrhagic stroke were included. For ischemic stroke, a modest increased risk was evident for all oral NSAIDs with adjusted ORs (95% CI) ranging from1.20 (1.00 to 1.44) for celecoxib to 1.90 (1.39 to 2.60) for ketorolac. For hemorrhagic stroke, oral ketorolac was associated with a significantly higher risk with OR of 2.69 (1.56 to 4.66). Significantly increased risk was found for parenteral NSAIDs, in particular ketorolac, with an OR of 3.92 (3.25 to 4.72) for ischemic stroke and 5.98 (4.40 to 8.13) for hemorrhagic stroke.Conclusions—Use of selective and nonselective NSAIDs was associated with an increased risk of both ischemic and hemorrhagic stroke, strikingly high for parenteral ketorolac.Keywords
This publication has 25 references indexed in Scilit:
- Use of a Prescribed Ephedrine/Caffeine Combination and the Risk of Serious Cardiovascular Events: A Registry-based Case-Crossover StudyAmerican Journal of Epidemiology, 2008
- Nonaspirin NSAIDs, Cyclooxygenase 2 Inhibitors, and the Risk for StrokeStroke, 2008
- Nonaspirin Nonsteroidal Anti-inflammatory Drugs and Hemorrhagic Stroke RiskStroke, 2008
- Cyclooxygenase-2 Inhibitors and Most Traditional Nonsteroidal Anti-inflammatory Drugs Cause Similar Moderately Increased Risks of Cardiovascular DiseaseJournal of Cardiovascular Pharmacology and Therapeutics, 2008
- Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trialsAnnals of the Rheumatic Diseases, 2007
- Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)PLoS Clinical Trials, 2006
- Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs and the Risk of Ischemic StrokeStroke, 2006
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006
- Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hospitalization for Intracerebral HemorrhageStroke, 2003
- Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory DrugsStroke, 2003